Hizentra - 44206-451-01 - (HUMAN IMMUNOGLOBULIN G)

Alphabetical Index


Drug Information of Hizentra

Product NDC: 44206-451
Proprietary Name: Hizentra
Non Proprietary Name: HUMAN IMMUNOGLOBULIN G
Active Ingredient(s): .2    g/mL & nbsp;   HUMAN IMMUNOGLOBULIN G
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Hizentra

Product NDC: 44206-451
Labeler Name: CSL Behring AG
Product Type: PLASMA DERIVATIVE
FDA Application Number: BLA125350
Marketing Category: BLA
Start Marketing Date: 20111003

Package Information of Hizentra

Package NDC: 44206-451-01
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (44206-451-01) > 5 mL in 1 VIAL, SINGLE-DOSE (44206-451-90)

NDC Information of Hizentra

NDC Code 44206-451-01
Proprietary Name Hizentra
Package Description 1 VIAL, SINGLE-DOSE in 1 CARTON (44206-451-01) > 5 mL in 1 VIAL, SINGLE-DOSE (44206-451-90)
Product NDC 44206-451
Product Type Name PLASMA DERIVATIVE
Non Proprietary Name HUMAN IMMUNOGLOBULIN G
Dosage Form Name LIQUID
Route Name SUBCUTANEOUS
Start Marketing Date 20111003
Marketing Category Name BLA
Labeler Name CSL Behring AG
Substance Name HUMAN IMMUNOGLOBULIN G
Strength Number .2
Strength Unit g/mL
Pharmaceutical Classes Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient]

Complete Information of Hizentra


General Information